Business Context and Reporting Period
This Form 8-K was filed by GoodRx Holdings, Inc. on December 17, 2020. The report details a specific corporate action regarding the issuance of unregistered equity securities to support the company's philanthropic initiatives under the GoodRxHelps program.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, or debt metrics. The only financial data disclosed relates to the specific transaction described below:
- Shares Issued: 1,075,000 shares of Class A common stock.
- Transaction Value: $107.50 aggregate consideration (issued at par value of $0.0001 per share).
- Funding Source: Proceeds from a cash donation of the same amount made by the Company to the Dechomai Asset Trust.
Material Changes
The material change reported is the issuance of 1,075,000 shares of Class A common stock to the Dechomai Asset Trust. These shares were previously reserved during the Company's initial public offering specifically to fund philanthropic initiatives. The transaction was executed on December 17, 2020, under a stock purchase agreement.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on future performance, or a discussion of general business risks. The transaction was executed in reliance on the exemption from registration contained in Section 4(a)(2) of the Securities Act of 1933, as it did not involve a public offering.
Key Facts for Investor Verification
- Verify the impact of the 1,075,000 share issuance on total outstanding share count and potential dilution.
- Confirm the operational status and funding requirements of the GoodRxHelps initiative.
- Note that the transaction involved a nominal cash outflow ($107.50) funded by a corresponding donation, resulting in no net cash impact from the transaction itself.